Burning rock reports third quarter 2023 financial results

Guangzhou, china, nov. 30, 2023 (globe newswire) -- burning rock biotech limited (nasdaq: bnr and lse: bnr, the “company” or “burning rock”), a company focused on the application of next generation sequencing (ngs) technology in the field of precision oncology, today reported financial results for the three months ended september 30, 2023. recent business updates therapy selection and minimal residual disease (mrd) personalized minimal residual disease (mrd) product, brprophettm supports advancement in early-stage non-small cell lung cancer treatment, with results published in the cancer cell in september 2023.
BNR Ratings Summary
BNR Quant Ranking